The Healthtech Podcast

This week, James is joined by Geoff von Maltzahn, CEO and co-founder at Tessera Therapeutics. Tessera is an early-stage biotech start-up that launched this summer with $50M in financing to pioneer a new category in ‘gene writing.’ Going even further than CRISPR, Tessera’s gene writing technology presents the potential to cure genetic disorders, cancers, and even infectious diseases like COVID-19. Geoffrey was awarded a Ph.D. in biomedical engineering and medical physics from MIT.
Get in touch with Geoff: @GVMaltzahn | https://www.linkedin.com/in/geoffrey-von-maltzahn-7a6b755a/
Subscribe to Healthtech Pigeon 🐦www.healthtechpigeon.com
Get in touch: www.jamessomauroo.com | www.somx.co.uk

Show Notes

This week, James is joined by Geoff von Maltzahn, CEO and co-founder at Tessera Therapeutics. Tessera is an early-stage biotech start-up that launched this summer with $50M in financing to pioneer a new category in ‘gene writing.’ Going even further than CRISPR, Tessera’s gene writing technology presents the potential to cure genetic disorders, cancers, and even infectious diseases like COVID-19. Geoffrey was awarded a Ph.D. in biomedical engineering and medical physics from MIT.

Get in touch with Geoff: @GVMaltzahn | https://www.linkedin.com/in/geoffrey-von-maltzahn-7a6b755a/

Subscribe to Healthtech Pigeon 🐦www.healthtechpigeon.com

Get in touch: www.jamessomauroo.com | www.somx.co.uk


Creators & Guests

Host
Dr James Somauroo
Cofounder of SomX

What is The Healthtech Podcast?

The Healthtech Podcast covers the latest in health and technology through interviews with disruptive healthtech startups and leaders. Whether you’re a patient, founder, investor or simply interested in healthtech, The Healthtech Podcast has it covered.

🌍 Listeners in over 150 countries.
🎙 New episode every week.
🗣 Hosted by Dr James Somauroo.

www.thehealthtechpodcast.com | www.somx.health | www.jamessomauroo.com